- Home
- NYCB vs GH Comparison
NYCB vs GH Comparison
Compare NYCB & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYCB
- GH
- Stock Information
- Founded
- NYCB 1859
- GH 2011
- Country
- NYCB United States
- GH United States
- Employees
- NYCB N/A
- GH N/A
- Industry
- NYCB Banks
- GH Medical Specialities
- Sector
- NYCB Finance
- GH Health Care
- Exchange
- NYCB Nasdaq
- GH Nasdaq
- Market Cap
- NYCB 3.9B
- GH 3.0B
- IPO Year
- NYCB 1993
- GH 2018
- Fundamental
- Price
- NYCB $10.80
- GH $23.73
- Analyst Decision
- NYCB Hold
- GH Strong Buy
- Analyst Count
- NYCB 15
- GH 17
- Target Price
- NYCB $13.58
- GH $39.31
- AVG Volume (30 Days)
- NYCB 4.9M
- GH 2.3M
- Earning Date
- NYCB 10-24-2024
- GH 11-04-2024
- Dividend Yield
- NYCB 6.47%
- GH N/A
- EPS Growth
- NYCB N/A
- GH N/A
- EPS
- NYCB N/A
- GH N/A
- Revenue
- NYCB $2,026,000,000.00
- GH $643,810,000.00
- Revenue This Year
- NYCB N/A
- GH $27.01
- Revenue Next Year
- NYCB N/A
- GH $18.30
- P/E Ratio
- NYCB N/A
- GH N/A
- Revenue Growth
- NYCB N/A
- GH 26.20
- 52 Week Low
- NYCB $5.10
- GH $15.81
- 52 Week High
- NYCB $36.54
- GH $37.04
- Technical
- Relative Strength Index (RSI)
- NYCB 50.23
- GH 31.05
- Support Level
- NYCB $10.05
- GH $25.51
- Resistance Level
- NYCB $11.11
- GH $26.85
- Average True Range (ATR)
- NYCB 0.47
- GH 1.07
- MACD
- NYCB -0.05
- GH -0.36
- Stochastic Oscillator
- NYCB 34.03
- GH 4.32
About NYCB New York Community Bancorp Inc.
New York Community Bancorp Inc is the bank holding company. It is a New York State-chartered savings bank that operates through eight local divisions: Queens County Savings Bank, Roslyn Savings Bank, Richmond County Savings Bank, Roosevelt Savings Bank, and Atlantic Bank in New York; Garden State Community Bank in New Jersey; Ohio Savings Bank in Ohio, and AmTrust Bank in Florida and Arizona. The bank competes for depositors in diverse markets with a comprehensive menu of products and services, and access to multiple service channels, including online banking, mobile banking, and banking by phone. It is also a producer of multi-family loans in New York City.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.